Skip to main content
. Author manuscript; available in PMC: 2011 May 17.
Published in final edited form as: Toxicol Pathol. 2010 Dec 21;39(1):240–266. doi: 10.1177/0192623310391680

Table 1.

Pulegone study design and results.

3 month male & female mice 0 9.375 18.75 37.5 75 150
3 month male rats 0 9.375 18.75 37.5 75*2/10 150*10/10
3 month female rats 0 9.375 18.75 37.5 75 150*8/10
2 year male mice 0 37.5*19/50 75*30/50 150*44/50
2 year female mice 0 37.5*3/50 75*15/50 150*41/50
2 year male rats 0 18.75 37.5*9/50 75*24/50
2 year female rats 0 37.5*17/50 75*49/50 150*48/49

Asterisks indicate groups in which hyaline glomerulopathy was observed in renal glomeruli. A dash indicates no dose. When the lesion was present, the incidence is indicated. Due to excessive morbidity and mortality, males given 75 mg/kg and females given 150 mg/kg did not receive pulegone after week 60 (stop-exposure), but instead were treated with corn oil vehicle until the end of the study.